| Ytd | -19.95% | |
| 1y | -19.29% |
| Open | 40.34 | Prev Close | 39.96 | Low | 39.57 | High | 41.24 | Mkt Cap | 4.78B |
| Vol | 2.17M | Avg Vol | 2.28M | EPS | 1.24 | P/E | 32.29 | Forward P/E | 11.99 |
| Beta | 1.39 | Short Ratio | 3.32 | Inst. Own | 108.78% | Dividend | 1.04 | Div Yield | 2.60 |
| Ex Div Date | 11-20 | Earning | 11-03 | 50-d Avg | 42.35 | 200-d Avg | 45.74 | 1yr Est | 52.00 |
FBIN News
As previously disclosed, as of June 27, 2026, Fortune Brands Innovations, Inc. (the "Company"
Fortune Brands Innovations, Inc. (NYSE: FBIN) ("Fortune Brands" or the "Company"), a
DEERFIELD, Ill.--(BUSINESS WIRE)--Fortune Brands Innovations, Inc. (NYSE: FBIN) (“Fortune Brands” or
Biopharma company Regeneron reported a solid set of results, with key drug Dupixent continuing to ou
The market is regaining confidence in Avantor's ability to grow organically and in Emmanuel Ligner's
DEERFIELD, Ill.--(BUSINESS WIRE)--Fortune Brands Innovations, Inc. (NYSE: FBIN) (“Fortune Brands” or
The Greenlight Capital funds returned -4.3% in Q2 2026 and 1.9% YTD, each net of fees and expenses.
Citigroup analyst Anthony Pettinari initiates coverage on Fortune Brands (NYSE:FBIN) with a Buy r
RBC Capital analyst Mike Dahl maintains Fortune Brands (NYSE:FBIN) with a Outperform and lowers t
Melius Research analyst Michael Rehaut initiates coverage on Fortune Brands (NYSE:FBIN) with a Ho
Barclays analyst Matthew Bouley maintains Fortune Brands (NYSE:FBIN) with a Equal-Weight and lowe
Evercore ISI Group analyst Stephen Kim maintains Fortune Brands (NYSE:FBIN) with a In-Line and lo
This whale alert can help traders discover the next big trading opportunities. Whales are entities w